L. Strauss

发表

Efficacy of postoperative chemotherapy using cisplatin plus etoposide in young children with brain tumors.

B. Maria, B. Carson, M. Wharam, 1991, Medical and pediatric oncology.

Dasatinib in advanced HER2/neu amplified and ER/PR-positive breast cancer: Phase II study CA180088.

H. Rugo, J. Sparano, M. Campone, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients

J. O’Shaughnessy, J. Goldschmidt, J. Blum, 2019, npj Breast Cancer.

Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium.

P. Adamson, F. Balis, S. Agrawal, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Two-phase [11C]L-methionine PET in childhood brain tumors.

A. Wilson, R. Dannals, H. Ravert, 1990, Pediatric neurology.

A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors

R. Kurzrock, A. Naing, D. Hong, 2013, Investigational New Drugs.

the International Association for the Study of Lung Cancer Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients

T. Zander, M. Odenthal, Y. Ko, 2015 .

Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib

J. Dipersio, H. Kantarjian, J. Cortes, 2018, Blood Cancer Journal.

Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy.

M. Greenwald, L. Strauss, 1996, Ophthalmology.

Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation.

M. Greenwald, L. Strauss, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Treatment of recurrent and refractory pediatric solid tumors with high-dose busulfan and cyclophosphamide followed by autologous bone marrow rescue.

C. Civin, P. Colombani, M. Wharam, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Positive stem cell selection--basic science.

M. Fackler, C. Civin, M. Loken, 1990, Progress in clinical and biological research.

Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia.

Andreas Hochhaus, R. Collins, H. Kantarjian, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Safety and activity of nivolumab (nivo) monotherapy and nivo in combination with ipilimumab (ipi) in recurrent glioblastoma (GBM): Updated results from checkmate-143.

T. Cloughesy, A. Omuro, D. Reardon, 2016 .

Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow.

C. Civin, M. Loken, L. Strauss, 1987, Experimental hematology.

Biomarker Analyses in Phase 2 Single-Agent Trials of Dasatinib for Breast Cancer.

L. Ploughman, D. Brickman, C. Harbison, 2009 .

Update of a phase 1 study of intravenous CCI-779 given in combination with interferon-α to patients with advanced renal cell carcinoma.

R. Motzer, R. Motzer, L. Galand, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single cell origin of multilineage colonies in culture. Evidence that differentiation of multipotent progenitors and restriction of proliferative potential of monopotent progenitors are stochastic processes.

C. Civin, M. Ogawa, A. G. Leary, 1984, The Journal of clinical investigation.

surface antigen on human marrow cells and leukemic cell lines Antigenic analysis of hematopoiesis. I. Expression of the My-1 granulocyte

R. Stuart, C. Civin, L. Strauss, 2011 .

Disparate differentiation in hemopoietic colonies derived from human paired progenitors.

C. Civin, M. Ogawa, A. G. Leary, 1985, Blood.

Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors.

B. Leventhal, B. Corden, R. Baumgardner, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of dasatinib in triple-negative breast cancer: results of study CA180059.

N. Ibrahim, J. Sparano, R. Finn, 2009 .

Elimination of clonogenic malignant human T cells using monoclonal antibodies in combination with 2'-deoxycoformycin.

J. Kurtzberg, C. Civin, C. Schwartz, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Localization of hematopoietic progenitor cells in tissue with the anti-My-10 monoclonal antibody.

C. Civin, W. Beschorner, L. Strauss, 1985, The American journal of pathology.

Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors

S. Piantadosi, P. Phillips, B. Carson, 1991, Journal of Neuro-Oncology.

Paclitaxel for the Treatment of Progressive or Recurrent Childhood Brain Tumors: A Pediatric Oncology Phase II Study

H. Friedman, J. Kepner, M. Harris, 2001, Journal of pediatric hematology/oncology.

An open-label, phase 1b, dose-escalation study (CA180-373) of dasatinib plus nivolumab, an investigational anti-programmed cell death 1 (PD-1) antibody, in patients (pts) with previously treated chronic myeloid leukemia (CML).

S. Mustjoki, J. Lipton, K. Porkka, 2014 .

Optimization of combination therapy for chronic myeloid leukemia with dosing constraints

U. Ledzewicz, Helen Moore, L. Strauss, 2018, Journal of Mathematical Biology.

Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors.

B. Leventhal, B. Corden, R. Baumgardner, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Selection of Normal Human Hematopoietic Stem Cells for Bone Marrow Transplantation Using Immunomagnetic Microspheres and CD34 Antibody

C. Civin, S. Rowley, T. Trischmann, 1991, The American journal of pediatric hematology/oncology.

Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells.

C. Civin, R. Stuart, V. L. La Russa, 1986, Experimental hematology.

Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.

M. Greenwald, L. Strauss, S. Goldman, 1998, Ophthalmology.

Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells.

M. Fackler, C. Civin, C. Civin, 1984, Journal of immunology.

Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium.

M. D. Den Boer, R. Pieters, A. Baruchel, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143

K. Ligon, T. Cloughesy, A. Omuro, 2018, Neuro-oncology.

A phase I study of cranial radiation therapy with concomitant continuous infusion paclitaxel in children with brain tumors.

L. Frankel, N. Vapiwala, N. Winick, 2001, Medical and pediatric oncology.

Radiation-agent combinations for glioblastoma: challenges in drug development and future considerations

C. N. Coleman, E. Galanis, Mansoor M Ahmed, 2017, Journal of Neuro-Oncology.

Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients

T. Zander, M. Odenthal, Y. Ko, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Antigenic analysis of hematopoiesis: II. Expression of human neutrophil antigens on normal and leukemic marrow cells.

J. August, C. Civin, K. Skubitz, 1984, Blood.

Dasatinib as a Single Agent in Triple-Negative Breast Cancer: Results of an Open-Label Phase 2 Study

N. Ibrahim, J. Sparano, R. Finn, 2011, Clinical Cancer Research.

A Phase 2 Trial of Dasatinib in Patients with Advanced HER2-Positive and/or Hormone Receptor–Positive Breast Cancer

Mario Campone, H. Rugo, M. Campone, 2011, Clinical Cancer Research.

Antigenic analysis of hematopoiesis. I. Expression of the My-1 granulocyte surface antigen on human marrow cells and leukemic cell lines.

C. Civin, R. Stuart, L. Strauss, 1983, Blood.

Optimization of combination therapy for chronic myeloid leukemia with dosing constraints

Urszula Ledzewicz, U. Ledzewicz, Helen Moore, 2018, Journal of Mathematical Biology.

Gene Signature–Guided Dasatinib Therapy in Metastatic Breast Cancer

Y. Qi, G. Hortobagyi, L. Pusztai, 2014, Clinical Cancer Research.

Personalized Medicine and Imaging Gene Signature – Guided Dasatinib Therapy in Metastatic Breast Cancer

G. Hortobagyi, L. Pusztai, W. Symmans, 2014 .

EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma.

R. Stupp, M. J. van den Bent, A. Brandes, 2012, Neuro-oncology.

Antigenic analysis of hematopoiesis. IV. The My-11 hematopoietic cell surface antigen is expressed by myelomonocytic and lymphoid, but not erythroid, progenitor cells.

M. Fackler, C. Civin, M. Loken, 1986, Experimental hematology.

DEVELOPMENT OF A SIMPLIFIED COUNTERFLOW CENTRIFUGATION ELUTRIATION PROCEDURE FOR DEPLETION OF LYMPHOCYTES FROM HUMAN BONE MARROW

A. Donnenberg, C. Civin, S. Noga, 1986, Transplantation.

Outcomes of a two‐drug chemotherapy regimen for intraocular retinoblastoma

P. Zage, R. Seshadri, M. Greenwald, 2008, Pediatric blood & cancer.

Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients

J. O’Shaughnessy, J. Goldschmidt, J. Blum, 2019, npj Breast Cancer.

PD01-02: Randomized Phase II Study of Dasatinib vs Placebo in Addition to Exemestane in Advanced ER/PR-Positive Breast Cancer [BMS CA180-261 Study].

G. Curigliano, J. Sohn, W. J. Geese, 2011 .

Dasatinib plus Capecitabine for Advanced Breast Cancer: Safety and Efficacy in Phase I Study CA180004

W. Gradishar, F. Atzori, G. Somlo, 2013, Clinical Cancer Research.

Response of a recurrent choroid plexus tumor to combination chemotherapy

B. Maria, M. Wharam, L. Strauss, 2004, Journal of Neuro-Oncology.

Two primary brain tumors in one child

B. Maria, L. Strauss, Moody D. Wharam, 1986, Neurology.

The role of hematopoietic growth factors and oncogenes in leukemogenesis.

M. Kastan, C. Civin, L. Strauss, 1989, American Journal Of Pediatric Hematology/Oncology.

A randomized, phase 3, open-label study of nivolumab versus temozolomide (TMZ) in combination with radiotherapy (RT) in adult patients (pts) with newly diagnosed, O-6-methylguanine DNA methyltransferase (MGMT)-unmethylated glioblastoma (GBM): CheckMate-498.

M. Weller, T. Cloughesy, N. Butowski, 2016 .

Secondary leukemia following successful treatment of Wilms' tumor.

S. Feig, T. Moss, L. Strauss, 1989, American Journal Of Pediatric Hematology/Oncology.

Histopathologic review of suspected disease progression in patients with recurrent glioblastoma (GBM) receiving nivolumab ± ipilimumab: CheckMate 143.

K. Ligon, T. Cloughesy, D. Reardon, 2017 .

Dasatinib plus capecitabine (Cap) for progressive advanced breast cancer (ABC): Phase I study CA180004.

W. Gradishar, F. Atzori, G. Somlo, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of histiocytosis X infiltrates with monoclonal antibodies directed against cells of histiocytic, lymphoid, and myeloid lineage.

C. Balch, C. Civin, G. Humphrey, 1986, Clinical immunology and immunopathology.

Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer

E. Rock, E. Van Cutsem, B. Melichar, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Dasatinib Plus Capecitabine for Advanced Breast Cancer: Safety and Efficacy Data from Phase 1 Study CA180-004.

W. Gradishar, L. Paz-Ares, G. Somlo, 2009 .

Three parallel randomized phase II trials of dasatinib plus hormone therapy (HT) in advanced ER+ breast cancer (ER+ ABC).

J. O’Shaughnessy, L. Strauss, A. Rybicki, 2010 .

Acquired chromosome rearrangements, including fine interstitial deletions, in a patient with Down syndrome and monoblastic leukemia.

J. Testa, S. Misawa, R. Leavitt, 1984, Pediatrics.

Dasatinib Plus Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML) with Resistance or Suboptimal Response to a Prior Tyrosine Kinase Inhibitor (TKI): Phase I Study CA180323

M. Copland, G. Martinelli, J. Cortes, 2014 .

Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib

J. Dipersio, H. Kantarjian, J. Cortes, 2018, Blood Cancer Journal.

Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history.

J. Charrow, M. Greenwald, L. Strauss, 1995, The Journal of pediatrics.

ATIM-16. NIVOLUMAB COMBINED WITH RADIOTHERAPY WITH OR WITHOUT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: RESULTS FROM PHASE 1 SAFETY COHORTS IN CHECKMATE 143

T. Cloughesy, N. Butowski, A. Omuro, 2016 .

Initiation in DNA synthesis by colony-stimulating factors in subsets of human CD34+ marrow cells.

C. Civin, L. Strauss, S. Welsh, 1991, Experimental hematology.

Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib

J. Dipersio, H. Kantarjian, J. Cortes, 2018, Blood Cancer Journal.

Pediatric phase I trial and pharmacokinetic (PK) study of dasatinib: A report from the Children's Oncology Group

P. Adamson, J. Wright, S. Shusterman, 2007 .

Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients

T. Zander, M. Odenthal, Y. Ko, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.